The medtech industry is positioned for continued growth as the aging world population faces many unmet medical needs. According to market analysts, industry revenue is predicted to grow to nearly $600 billion in 2024, with the cardiovascular, orthopedic, neurological, urological, and diabetes sectors driving that growth.
Several trends are shaping the medtech industry, presenting
Corporate boards will be called upon to renew their oversight of corporate compliance following the recent announcement of several new corporate fraud enforcement initiatives by the U.S. Department of Justice (DOJ). Most notably, these include a new whistleblower program and the expectation that effective compliance programs will monitor the risks of companies’ misuse of emerging
As ESG-related litigation has developed, one definitive trend has been the emergence of litigation involving allegations of “greenwashing” – that is, claims alleging that companies overstated their ESG credentials in order to win business, attract customers, or score virtue points. To date, the greenwashing claims have emerged primarily in the U.S. and Europe.
In a speech before the Yale Law School February 2024, SEC Chair Gary Gensler had AI top of mind. Interrupted only by a colorful collection of movie references, Chair Gensler focused almost the entirety of his remarks on AI and the SEC’s corresponding regulatory duties. Chair Gensler addressed the risks associated with AI while cautioning
How do directors add value to corporations, and what are their incentives? They add value through monitoring and advising management – although monitoring seems to have taken precedence in the wake of high-profile financial scandals. As for directors’ incentives, the answer is less straightforward. While director compensation has increased in recent years, non-pecuniary incentives remain
Last week, when I wrote about two recent AI-related SEC enforcement actions, I noted that the SEC’s public statements when it announced the enforcement action settlements not only underscored the SEC’s AI-related concerns but also illustrated the kinds of issues that could lead to private securities litigation brought by investors who claim they were misled
As the capabilities of generative artificial intelligence have increased, so have concerns that generative AI might be used to manipulate voters and the administration of elections in the 2024 presidential election and primaries. The first warning shot came in New Hampshire on January 21, 2024, two days before the New Hampshire Presidential Primary Election, when
Across the legal sector, generative AI has dominated headlines for the past year. Specific to the in-house community, it’s been reported that 25 percentto83 percent of Legal Departments are using AI tools.
Some readers may recall that at the end of last year, the New York Times very publicly sued OpenAI and Microsoft for copyright infringement, in connection with the defendants’ alleged use of the newspaper’s content for purposes of training chatbots and other AI tools. Although this kind of lawsuit is pretty far outside the blog’s
Background
On March 18, 2024, the Securities and Exchange Commission announced settled charges against two SEC registered investment advisers for making false and misleading statements about their purported use of artificial intelligence (“AI”). The firms agreed to settle the SEC’s charges and pay $400,000 in total civil penalties.
Cause of Action
One firm’s charges arose